region stringclasses 1
value | symbol stringlengths 1 5 | exchange stringclasses 8
values | quote_type stringclasses 2
values | currency stringclasses 1
value | name stringlengths 2 84 ⌀ | sector stringclasses 12
values | industry stringclasses 148
values | close float64 0 5.92k ⌀ | volume float64 0 134M ⌀ | market_cap float64 22.4k 2,794B ⌀ | updated_at timestamp[ns] | long_business_summary stringlengths 50 5.19k ⌀ | status stringclasses 1
value | __index_level_0__ int64 0 7.31k |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
US | A | NYQ | EQUITY | USD | Agilent Technologies, Inc. | Healthcare | Diagnostics & Research | 110.51 | 1,630,440 | 32,623,452,160 | 2023-10-17T07:00:20.700000 | Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and ... | null | 1 |
US | AA | NYQ | EQUITY | USD | Alcoa Corporation | Basic Materials | Aluminum | 26.58 | 4,935,756 | 4,784,244,224 | 2023-10-17T07:00:28.310000 | Alcoa Corporation, together with its subsidiaries, produces and sells bauxite, alumina, and aluminum products in the United States, Spain, Australia, Iceland, Norway, Brazil, Canada, and internationally. The company operates through three segments: Bauxite, Alumina, and Aluminum. It engages in bauxite mining operations... | null | 2 |
US | AAC | NYQ | EQUITY | USD | Ares Acquisition Corporation | Financial Services | Shell Companies | 10.78 | 38,167 | 759,702,336 | 2023-10-17T07:00:34.752000 | Ares Acquisition Corporation does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Ares Acquisition Corporation was incorporated in 2020 and is based in New York, New Y... | null | 3 |
US | AACG | NGM | EQUITY | USD | ATA Creativity Global | Consumer Defensive | Education & Training Services | 1.1 | 1,430 | 34,744,492 | 2023-10-17T07:00:42.395000 | ATA Creativity Global, together with its subsidiaries, provides educational services to individual students through its training center network in China and internationally. Its educational services include portfolio training, research-based learning, overseas study counselling, in-school art classes through cooperatio... | null | 4 |
US | AACI | NGM | EQUITY | USD | Armada Acquisition Corp. I | Financial Services | Shell Companies | 10.69 | 100 | 86,540,952 | 2023-10-17T07:00:50.322000 | Armada Acquisition Corp. I focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to focus on target businesses that provide technological services to the financial services industry. Armada Acquis... | null | 5 |
US | AACT | NYQ | EQUITY | USD | Ares Acquisition Corporation II | Financial Services | Shell Companies | 10.29 | 128,759 | 643,124,992 | 2023-10-17T07:00:56.346000 | Ares Acquisition Corporation II focuses on effecting a merger, share exchange, share purchase, asset acquisition, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in New York, New York. | null | 6 |
US | AADI | NCM | EQUITY | USD | Aadi Bioscience, Inc. | Healthcare | Biotechnology | 4.23 | 81,559 | 103,473,976 | 2023-10-17T07:01:02.608000 | Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug product candidate comprises FYARRO, a form of sirolimus bound to albumin. The company is also involved in... | null | 7 |
US | AAIC | NYQ | EQUITY | USD | Arlington Asset Investment Corp. | Real Estate | REIT - Mortgage | 4.36 | 73,564 | 129,415,832 | 2023-10-17T07:01:10.302000 | Arlington Asset Investment Corp. (NYSE: AAIC) currently invests primarily in mortgage related and residential real estate and has elected to be taxed as a REIT. The Company is headquartered in the Washington, D.C. metropolitan area. For more information, please visit www.arlingtonasset.com. | null | 8 |
US | AAL | NMS | EQUITY | USD | American Airlines Group Inc. | Industrials | Airlines | 11.72 | 35,116,077 | 7,801,141,760 | 2023-10-17T07:01:16.457000 | American Airlines Group Inc., through its subsidiaries, operates as a network air carrier. The company provides scheduled air transportation services for passengers and cargo through its hubs in Charlotte, Chicago, Dallas/Fort Worth, Los Angeles, Miami, New York, Philadelphia, Phoenix, and Washington, D.C., as well as ... | null | 9 |
US | AAMC | ASE | EQUITY | USD | Altisource Asset Management Corporation | Financial Services | Mortgage Finance | 6.71 | 10,657 | 11,487,937 | 2023-10-17T07:01:24.384000 | AAMC has historically been an asset management company that provides portfolio management and corporate governance services to investment vehicles but given the sale and discontinuance of certain operations the Company is in the process of repositioning itself. Additional information is available at www.altisourceamc.c... | null | 10 |
US | AAME | NGM | EQUITY | USD | Atlantic American Corporation | Financial Services | Insurance - Life | 1.86 | 6,827 | 37,132,188 | 2023-10-17T07:01:30.419000 | Atlantic American Corporation, through its subsidiaries, provides life and health, and property and casualty insurance products in the United States. It operates through American Southern and Bankers Fidelity segments. The company offers property and casualty insurance products, including business automobile insurance ... | null | 11 |
US | AAN | NYQ | EQUITY | USD | The Aaron's Company, Inc. | Industrials | Rental & Leasing Services | 9.37 | 355,421 | 305,294,432 | 2023-10-17T07:01:37.752000 | The Aaron's Company, Inc. provides lease-to-own and retail purchase solutions. It operates through Aaron's Business and BrandsMart segments. The company engages in direct-to-consumer sales and lease ownership of furniture, appliances, electronics, computers, and other home products through company-operated and franchis... | null | 12 |
US | AAOI | NGM | EQUITY | USD | Applied Optoelectronics, Inc. | Technology | Communication Equipment | 7.55 | 989,206 | 255,070,128 | 2023-10-17T07:01:43.453000 | Applied Optoelectronics, Inc. designs, manufactures, and sells various fiber-optic networking products worldwide. It offers optical modules, lasers, subassemblies, transmitters and transceivers, and turn-key equipment, as well as headend, node, and distribution equipment. The company sells its products to internet data... | null | 13 |
US | AAON | NMS | EQUITY | USD | AAON, Inc. | Industrials | Building Products & Equipment | 56.16 | 196,418 | 4,703,155,712 | 2023-10-17T07:01:49.971000 | AAON, Inc., together with its subsidiaries, engages in engineering, manufacturing, marketing, and selling air conditioning and heating equipment in the United States and Canada. The company operates through three segments: AAON Oklahoma, AAON Coil Products, and BASX. It offers rooftop units, data center cooling solutio... | null | 14 |
US | AAP | NYQ | EQUITY | USD | Advance Auto Parts, Inc. | Consumer Cyclical | Specialty Retail | 50.75 | 2,015,009 | 3,187,013,376 | 2023-10-17T07:01:56.450000 | Advance Auto Parts, Inc. provides automotive replacement parts, accessories, batteries, and maintenance items for domestic and imported cars, vans, sport utility vehicles, and light and heavy duty trucks. The company offers battery accessories; belts and hoses; brakes and brake pads; chassis and climate control parts; ... | null | 15 |
US | AAPL | NMS | EQUITY | USD | Apple Inc. | Technology | Consumer Electronics | 178.85 | 52,257,826 | 2,794,144,137,216 | 2023-10-17T07:02:02.453000 | Apple Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide. The company offers iPhone, a line of smartphones; Mac, a line of personal computers; iPad, a line of multi-purpose tablets; and wearables, home, and accessories comprising AirPods, Apple TV, App... | null | 16 |
US | AAT | NYQ | EQUITY | USD | American Assets Trust, Inc. | Real Estate | REIT - Diversified | 18.29 | 150,144 | 1,440,453,120 | 2023-10-17T07:02:11.111000 | American Assets Trust, Inc. is a full service, vertically integrated and self-administered real estate investment trust ("REIT"), headquartered in San Diego, California. The company has over 55 years of experience in acquiring, improving, developing and managing premier office, retail, and residential properties throug... | null | 17 |
US | AAU | ASE | EQUITY | USD | Almaden Minerals Ltd. | Basic Materials | Gold | 0.136 | 254,879 | 18,911,340 | 2023-10-17T07:02:19.863000 | Almaden Minerals Ltd., an exploration stage company, engages in the acquisition, exploration, evaluation, and development of mineral properties in Mexico. The company's principal asset includes a 100% interest in the Ixtaca gold-silver project located in Puebla State, Mexico. Almaden Minerals Ltd. was incorporated in 1... | null | 18 |
US | AB | NYQ | EQUITY | USD | AllianceBernstein Holding L.P. | Financial Services | Asset Management | 29.4 | 111,377 | 3,366,209,792 | 2023-10-17T07:02:27.645000 | AllianceBernstein Holding L.P. is a publicly owned investment manager. The firm is a related adviser The firm manages separate client focused portfolios for its clients. The firm primarily invests in common and preferred stocks, warrants and convertible securities, government and corporate fxed-income securities, commo... | null | 19 |
US | ABBV | NYQ | EQUITY | USD | AbbVie Inc. | Healthcare | Drug Manufacturers - General | 147.96 | 3,687,161 | 259,868,295,168 | 2023-10-17T07:02:35.773000 | AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinv... | null | 20 |
US | ABC | NYQ | EQUITY | USD | AmerisourceBergen Corporation | Healthcare | Medical Distribution | 180.39 | 806,054 | 36,149,702,656 | 2023-10-17T07:02:43.279000 | AmerisourceBergen Corporation sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independ... | null | 21 |
US | ABCB | NMS | EQUITY | USD | Ameris Bancorp | Financial Services | Banks - Regional | 37.66 | 225,745 | 2,661,171,712 | 2023-10-17T07:02:51.331000 | Ameris Bancorp operates as the bank holding company for Ameris Bank that provides range of banking services to retail and commercial customers primarily in Georgia, Alabama, Florida, North Carolina, and South Carolina. It operates through five segments: Banking Division, Retail Mortgage Division, Warehouse Lending Divi... | null | 22 |
US | ABCL | NMS | EQUITY | USD | AbCellera Biologics Inc. | Healthcare | Biotechnology | 4.26 | 1,129,536 | 1,238,443,776 | 2023-10-17T07:02:59.126000 | AbCellera Biologics Inc. builds an engine for antibody drug discovery and development. Its engine discovers antibodies from natural immune responses, which are pre-enriched for antibodies. The company had discovery programs that are either completed, in progress, or under contract with partners. It has a research colla... | null | 23 |
US | ABCM | NMS | EQUITY | USD | Abcam plc | Healthcare | Biotechnology | 22.61 | 2,988,277 | 5,274,440,192 | 2023-10-17T07:03:07.533000 | Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. The company's principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex immunoassays; proteins an... | null | 24 |
US | ABEO | NCM | EQUITY | USD | Abeona Therapeutics Inc. | Healthcare | Biotechnology | 4.14 | 31,521 | 105,460,136 | 2023-10-17T07:03:14.199000 | Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases. Its lead clinical program is EB-101, an autologous, engineered cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ... | null | 25 |
US | ABEV | NYQ | EQUITY | USD | Ambev S.A. | Consumer Defensive | Beverages - Brewers | 2.55 | 8,125,182 | 41,560,064,000 | 2023-10-17T07:03:20.611000 | Ambev S.A., through its subsidiaries, engages in the production, distribution, and sale of beer, draft beer, carbonated soft drinks, other non-alcoholic beverages, malt, and food products. It offers beer primarily under the Skol, Brahma, Antarctica, Brahva, Budweiser, Bud Light, Beck, Leffe and Hoegaarden, Bucanero, Cr... | null | 26 |
US | ABG | NYQ | EQUITY | USD | Asbury Automotive Group, Inc. | Consumer Cyclical | Auto & Truck Dealerships | 212.4 | 74,236 | 4,447,946,752 | 2023-10-17T07:03:27.579000 | Asbury Automotive Group, Inc., together with its subsidiaries, operates as an automotive retailer in the United States. It offers a range of automotive products and services, including new and used vehicles; and vehicle repair and maintenance services, replacement parts, and collision repair services. The company also ... | null | 27 |
US | ABIO | NCM | EQUITY | USD | ARCA biopharma, Inc. | Healthcare | Biotechnology | 2.02 | 14,253 | 29,108,402 | 2023-10-17T07:03:35.516000 | ARCA biopharma, Inc., a clinical development stage biopharmaceutical company, engages in the development and commercialization of genetically targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase... | null | 28 |
US | ABL | NCM | EQUITY | USD | Abacus Life, Inc. | Financial Services | Insurance - Life | 6.37 | 3,334 | 402,954,880 | 2023-10-17T07:03:42.032000 | Abacus Life, Inc. operates as an alternative asset manager specializing in life insurance products. It purchases life insurance policies from consumers seeking liquidity and manages policies over time via trading, holding, and/or servicing. The company was founded in 2004 and is based in Orlando, Florida. | null | 29 |
US | ABLV | NCM | EQUITY | USD | Able View Global Inc. | Communication Services | Advertising Agencies | 3 | 6,654 | 52,113,644 | 2023-10-17T07:03:48.417000 | Able View Global Inc. operates as brand management partners of beauty and personal care brands in China. Its brand management services encompass various segments of the brand management value chain, including strategy, branding, digital and social marketing, omni-channel sales, customer service, overseas logistics, war... | null | 30 |
US | ABM | NYQ | EQUITY | USD | ABM Industries Incorporated | Industrials | Specialty Business Services | 44.03 | 303,531 | 2,867,688,960 | 2023-10-17T07:03:55.639000 | ABM Industries Incorporated, through its subsidiaries, engages in the provision of integrated facility, infrastructure, and mobility solutions in the United States and internationally. The company operates through Business & Industry, Manufacturing & Distribution, Education, Aviation, and Technical Solutions segments. ... | null | 31 |
US | ABNB | NMS | EQUITY | USD | Airbnb, Inc. | Consumer Cyclical | Travel Services | 124.08 | 2,662,069 | 79,881,732,096 | 2023-10-17T07:04:04.029000 | Airbnb, Inc., together with its subsidiaries, operates a platform that enables hosts to offer stays and experiences to guests worldwide. The company's marketplace model connects hosts and guests online or through mobile devices to book spaces and experiences. It primarily offers private rooms, primary homes, or vacatio... | null | 32 |
US | ABOS | NMS | EQUITY | USD | Acumen Pharmaceuticals, Inc. | Healthcare | Biotechnology | 3.74 | 313,324 | 217,006,880 | 2023-10-17T07:04:10.183000 | Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloi... | null | 33 |
US | ABR | NYQ | EQUITY | USD | Arbor Realty Trust, Inc. | Real Estate | REIT - Mortgage | 14.23 | 1,922,274 | 2,722,929,152 | 2023-10-17T07:04:18.175000 | Arbor Realty Trust, Inc. invests in a diversified portfolio of structured finance assets in the multifamily, single-family rental, and commercial real estate markets in the United States. The company operates in two segments, Structured Business and Agency Business. It primarily invests in bridge and mezzanine loans, i... | null | 34 |
US | ABSI | NMS | EQUITY | USD | Absci Corporation | Healthcare | Biotechnology | 1.34 | 330,867 | 132,576,728 | 2023-10-17T07:04:26.546000 | Absci Corporation operates as a generative AI drug creation company in the United States. Its integrated drug creation platform identifies novel drug targets and creates biotherapeutic candidates. The company was founded in 2011 and is headquartered in Vancouver, Washington. | null | 35 |
US | ABST | null | null | null | null | null | null | null | null | null | null | null | error | 36 |
US | ABT | NYQ | EQUITY | USD | Abbott Laboratories | Healthcare | Medical Devices | 90.87 | 6,422,489 | 159,965,478,912 | 2023-10-17T07:04:33.237000 | Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides ge... | null | 37 |
US | ABUS | NMS | EQUITY | USD | Arbutus Biopharma Corporation | Healthcare | Biotechnology | 1.86 | 415,284 | 316,682,720 | 2023-10-17T07:04:41.678000 | Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously-delivered RNAi therapeutic product candidate that sup... | null | 38 |
US | ABVC | NCM | EQUITY | USD | ABVC BioPharma, Inc. | Healthcare | Biotechnology | 0.94 | 62,305 | 3,714,306 | 2023-10-17T07:04:47.943000 | ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase II clinical trials a combination therapy for triple negative breast cancer; ABV-1504 has completed Phase II clin... | null | 39 |
US | AC | NYQ | EQUITY | USD | Associated Capital Group, Inc. | Financial Services | Asset Management | 34.27 | 4,089 | 739,808,384 | 2023-10-17T07:04:54.938000 | Associated Capital Group, Inc., together with its subsidiaries, provides investment advisory services in the United States. The company offers alternative investment management and asset management services. It also invests in new and existing businesses. The company was founded in 1976 and is headquartered in Greenwic... | null | 40 |
US | ACA | NYQ | EQUITY | USD | Arcosa, Inc. | Industrials | Engineering & Construction | 68.2 | 106,038 | 3,392,358,400 | 2023-10-17T07:05:01.469000 | Arcosa, Inc., together with its subsidiaries, provides infrastructure-related products and solutions for the construction, engineered structures, and transportation markets in North America. It operates through three segments: Construction Products, Engineered Structures, and Transportation Products. The Construction P... | null | 41 |
US | ACAB | NGM | EQUITY | USD | Atlantic Coastal Acquisition Corp. II | Financial Services | Shell Companies | 10.59 | 1 | 115,809,064 | 2023-10-17T07:05:09.793000 | Atlantic Coastal Acquisition Corp. II does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses in financial services industry and mobility sector. Atlan... | null | 42 |
US | ACAC | NCM | EQUITY | USD | Acri Capital Acquisition Corporation | Financial Services | Shell Companies | 10.99 | 853 | 63,393,344 | 2023-10-17T07:05:17.337000 | Acri Capital Acquisition Corporation does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses. It intends to focus its search on the technology-enabled sectors, including e... | null | 43 |
US | ACAD | NMS | EQUITY | USD | ACADIA Pharmaceuticals Inc. | Healthcare | Biotechnology | 23.14 | 1,245,483 | 3,893,475,584 | 2023-10-17T07:05:24.235000 | ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization innovative medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated wit... | null | 44 |
US | ACAH | NCM | EQUITY | USD | Atlantic Coastal Acquisition Corp. | Financial Services | Shell Companies | 10.48 | 7,566 | 127,533,224 | 2023-10-17T07:05:30.575000 | Atlantic Coastal Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in mobility sector. The company was incorporated in 2020 and is based in New York... | null | 45 |
US | ACAQ | ASE | EQUITY | USD | Athena Consumer Acquisition Corp. | Financial Services | Shell Companies | 9.4 | 32,710 | 98,243,928 | 2023-10-17T07:05:36.989000 | Athena Consumer Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to identify business opportunities in the field of technol... | null | 46 |
US | ACAX | NGM | EQUITY | USD | Alset Capital Acquisition Corp. | Financial Services | Shell Companies | 10.66 | 71 | 48,363,420 | 2023-10-17T07:05:44.404000 | Alset Capital Acquisition Corp. does not have any significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. Alset Capital Acquisition Corp. was incorporated in 2021 and is bas... | null | 47 |
US | ACB | NCM | EQUITY | USD | Aurora Cannabis Inc. | Healthcare | Drug Manufacturers - Specialty & Generic | 0.5039 | 6,297,689 | 228,237,632 | 2023-10-17T07:05:50.092000 | Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consum... | null | 48 |
US | ACBA | NCM | EQUITY | USD | Ace Global Business Acquisition Limited | Financial Services | Shell Companies | 11.62 | 43 | 40,359,980 | 2023-10-17T07:05:57.091000 | Ace Global Business Acquisition Limited does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses. It intends to focus on businesses in the Greater China, ... | null | 49 |
US | ACCD | NMS | EQUITY | USD | Accolade, Inc. | Healthcare | Health Information Services | 7.02 | 583,588 | 545,822,528 | 2023-10-17T07:06:04.208000 | Accolade, Inc., together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technolo... | null | 50 |
US | ACCO | NYQ | EQUITY | USD | ACCO Brands Corporation | Industrials | Business Equipment & Supplies | 5.24 | 244,623 | 504,011,392 | 2023-10-17T07:06:12.538000 | ACCO Brands Corporation designs, manufactures, and markets consumer, school, technology, and office products. It operates through three segments: ACCO Brands North America, ACCO Brands EMEA, and ACCO Brands International. The company provides computer and gaming accessories, planners, dry erase boards, school notebooks... | null | 51 |
US | ACDC | NMS | EQUITY | USD | ProFrac Holding Corp. | Energy | Oil & Gas Equipment & Services | 9.56 | 574,782 | 1,509,404,416 | 2023-10-17T07:06:19.100000 | ProFrac Holding Corp., an integrated energy services company, provides stimulation services, proppants production, and other complementary products and services to oil and gas companies in the United States. It operates through three segments: Stimulation Services, Manufacturing, and Proppant Production. The company al... | null | 52 |
US | ACEL | NYQ | EQUITY | USD | Accel Entertainment, Inc. | Consumer Cyclical | Gambling | 10.22 | 258,460 | 869,856,512 | 2023-10-17T07:06:27.331000 | Accel Entertainment, Inc., together with its subsidiaries, operates as a distributed gaming operator in the United States. It is involved in the installation, maintenance, and operation of gaming terminals; redemption devices that disburse winnings and contain automated teller machine (ATM) functionality; and other amu... | null | 53 |
US | ACER | NCM | EQUITY | USD | Acer Therapeutics Inc. | Healthcare | Biotechnology | 0.76 | 38,422 | 19,081,686 | 2023-10-17T07:06:35.211000 | Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. The company's pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients ... | null | 54 |
US | ACET | NGM | EQUITY | USD | Adicet Bio, Inc. | Healthcare | Biotechnology | 1.38 | 200,904 | 61,584,664 | 2023-10-17T07:06:43.876000 | Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and chimeric adaptors to enhance selective tumor targeting, facilitate innate and adap... | null | 55 |
US | ACGL | NMS | EQUITY | USD | Arch Capital Group Ltd. | Financial Services | Insurance - Diversified | 84.16 | 2,095,641 | 31,962,155,008 | 2023-10-17T07:06:51.856000 | Arch Capital Group Ltd., together with its subsidiaries, provides insurance, reinsurance, and mortgage insurance products worldwide. The company's Insurance segment offers primary and excess casualty coverages; loss sensitive primary casualty insurance programs; collateral protection, debt cancellation, and service con... | null | 56 |
US | ACGLO | NMS | EQUITY | USD | Arch Capital Group Ltd. | Financial Services | Insurance - Diversified | 19.8 | 23,612 | 11,504,346,112 | 2023-10-17T07:06:58.520000 | Arch Capital Group Ltd., together with its subsidiaries, provides insurance, reinsurance, and mortgage insurance products worldwide. The company's Insurance segment offers primary and excess casualty coverages; loss sensitive primary casualty insurance programs; collateral protection, debt cancellation, and service con... | null | 57 |
US | ACGN | NCM | EQUITY | USD | Aceragen, Inc. | Healthcare | Biotechnology | 0.3849 | 52,509 | 3,240,965 | 2023-10-17T07:07:06.743000 | Aceragen, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare pulmonary and rheumatic diseases in the United States. Its clinical development pipeline includes ACG-701, which is in Phase 2 clinical trial for cystic fibrosis pulmonary exacerbat... | null | 58 |
US | ACHC | NMS | EQUITY | USD | Acadia Healthcare Company, Inc. | Healthcare | Medical Care Facilities | 76.33 | 498,203 | 7,187,557,376 | 2023-10-17T07:07:12.920000 | Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. It offers behavioral healthcare services to its patients in various settings, including inpatient psychiatric facilities, specialty treatment facilities, residential treatment centers, eating disorder facilitie... | null | 59 |
US | ACHL | NMS | EQUITY | USD | Achilles Therapeutics plc | Healthcare | Biotechnology | 0.89 | 35,228 | 36,442,116 | 2023-10-17T07:07:20.012000 | Achilles Therapeutics Plc, a clinical stage immuno-oncology biopharmaceutical company, develops precision T cell therapies to treat various solid tumors. The company's lead product candidates include CHIRON, which is in Phase I/IIa clinical trial for use in the treatment of advanced non-small cell lung cancer; and THET... | null | 60 |
US | ACHR | NYQ | EQUITY | USD | Archer Aviation Inc. | Industrials | Aerospace & Defense | 5.11 | 3,130,262 | 1,476,253,952 | 2023-10-17T07:07:26.185000 | Archer Aviation Inc., an urban air mobility company, engages in designs, develops, manufactures, and operates electric vertical takeoff and landing aircrafts to carry passengers. The company was formerly known as Atlas Crest Investment Corp. and changed its name to Archer Aviation Inc. Archer Aviation Inc. was incorpor... | null | 61 |
US | ACHV | NCM | EQUITY | USD | Achieve Life Sciences, Inc. | Healthcare | Biotechnology | 3.72 | 59,414 | 79,779,920 | 2023-10-17T07:07:33.439000 | Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain ... | null | 62 |
US | ACI | NYQ | EQUITY | USD | Albertsons Companies, Inc. | Consumer Defensive | Grocery Stores | 22.4 | 3,107,585 | 12,952,776,704 | 2023-10-17T07:07:42.019000 | Albertsons Companies, Inc., through its subsidiaries, engages in the operation of food and drug stores in the United States. The company's food and drug retail stores offer grocery products, general merchandise, health and beauty care products, pharmacy, fuel, and other items and services. It also manufactures and proc... | null | 63 |
US | ACIC | NCM | EQUITY | USD | American Coastal Insurance Corporation | Financial Services | Insurance - Property & Casualty | 7.5 | 217,990 | 325,548,736 | 2023-10-17T07:07:49.202000 | American Coastal Insurance Corporation operates as a property and casualty insurance holding company that sources, writes, and services residential personal and commercial property, and casualty insurance policies in the United States. The company offers structure, content, and liability coverage for standard single-fa... | null | 64 |
US | ACIU | NGM | EQUITY | USD | AC Immune SA | Healthcare | Biotechnology | 2.78 | 8,973 | 223,028,560 | 2023-10-17T07:07:55.733000 | AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and smal... | null | 65 |
US | ACIW | NMS | EQUITY | USD | ACI Worldwide, Inc. | Technology | Software - Infrastructure | 20.26 | 275,638 | 2,257,690,112 | 2023-10-17T07:08:02.056000 | ACI Worldwide, Inc., a software company, develops, markets, installs, and supports a range of software products and solutions for facilitating digital payments in the United States and internationally. The company operates in three segments: Banks, Merchants, and Billers. The company offers ACI Acquiring, a merchant ma... | null | 66 |
US | ACLS | NMS | EQUITY | USD | Axcelis Technologies, Inc. | Technology | Semiconductor Equipment & Materials | 160.37 | 433,327 | 5,350,893,568 | 2023-10-17T07:08:09.362000 | Axcelis Technologies, Inc. designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements. ... | null | 67 |
US | ACLX | NMS | EQUITY | USD | Arcellx, Inc. | Healthcare | Biotechnology | 33.13 | 312,092 | 1,647,107,584 | 2023-10-17T07:08:16.716000 | Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 2 clinical trial for the treatment of patients with relapsed or refractory (r/r... | null | 68 |
US | ACM | NYQ | EQUITY | USD | AECOM | Industrials | Engineering & Construction | 80.75 | 515,538 | 11,414,458,368 | 2023-10-17T07:08:22.559000 | AECOM, together with its subsidiaries, provides professional infrastructure consulting services worldwide. It operates in three segments: Americas, International, and AECOM Capital. The company offers planning, consulting, architectural and engineering design, construction and program management, and investment and dev... | null | 69 |
US | ACMR | NGM | EQUITY | USD | ACM Research, Inc. | Technology | Semiconductor Equipment & Materials | 19 | 1,005,452 | 1,118,219,136 | 2023-10-17T07:08:31.065000 | ACM Research, Inc., together with its subsidiaries, develops, manufactures, and sells single-wafer wet cleaning equipment for enhancing the manufacturing process and yield for integrated chips worldwide. It offers space alternated phase shift technology for flat and patterned wafer surfaces, which employs alternating p... | null | 70 |
US | ACN | NYQ | EQUITY | USD | Accenture plc | Technology | Information Technology Services | 301.83 | 1,427,637 | 192,058,851,328 | 2023-10-17T07:08:36.916000 | Accenture plc, a professional services company, provides strategy and consulting, industry X, song, and technology and operation services worldwide. The company offers application services, including agile transformation, DevOps, application modernization, enterprise architecture, software and quality engineering, data... | null | 71 |
US | ACNB | NCM | EQUITY | USD | ACNB Corporation | Financial Services | Banks - Regional | 32.92 | 11,887 | 283,049,440 | 2023-10-17T07:08:43.423000 | ACNB Corporation, a financial holding company, offers banking, insurance, and financial services to individual, business, and government customers in the United States. The company provides checking, savings, and money market deposit accounts, as well as time deposits and debit cards. It also offers commercial lending ... | null | 72 |
US | ACNT | NGM | EQUITY | USD | Ascent Industries Co. | Basic Materials | Steel | 8.05 | 14,923 | 78,557,672 | 2023-10-17T07:08:50.431000 | Ascent Industries Co. an industrials company, focuses on the production and distribution of industrial tubular products and specialty chemicals in the United States and internationally. The company operates through two segments, Tubular Products and Specialty Chemicals. It manufactures welded pipes and tubes, primarily... | null | 73 |
US | ACON | NCM | EQUITY | USD | Aclarion, Inc. | Healthcare | Health Information Services | 0.539 | 16,295 | 4,181,099 | 2023-10-17T07:08:56.334000 | Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. The company develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final... | null | 74 |
US | ACOR | NMS | EQUITY | USD | Acorda Therapeutics, Inc. | Healthcare | Drug Manufacturers - Specialty & Generic | 10 | 30,093 | 12,296,790 | 2023-10-17T07:09:04.682000 | Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in adults with multiple sclerosis; and Inbrija, an inhaled levodopa for intermittent treatment of OFF... | null | 75 |
US | ACP | NYQ | EQUITY | USD | Abrdn Income Credit Strategies Fund | Financial Services | Asset Management | 6.39 | 223,307 | 331,721,568 | 2023-10-17T07:09:12.280000 | Abrdn Income Credit Strategies Fund is a closed-ended fixed income fund launched and managed by Aberdeen Asset Managers Limited. It is co-managed by Aberdeen Standard Investments Inc. The fund invests in fixed income markets across the globe. It seeks to invest primarily in loan and debt instruments. Abrdn Income Credi... | null | 76 |
US | ACR | NYQ | EQUITY | USD | ACRES Commercial Realty Corp. | Real Estate | REIT - Mortgage | 8.15 | 7,029 | 68,275,520 | 2023-10-17T07:09:20.568000 | ACRES Commercial Realty Corp., a real estate investment trust (REIT), focuses on the origination, holding, and management of commercial real estate mortgage loans and other commercial real estate-related debt investments in the United States. It invests in commercial real estate-related assets, including floating and f... | null | 77 |
US | ACRE | NYQ | EQUITY | USD | Ares Commercial Real Estate Corporation | Real Estate | REIT - Mortgage | 9.27 | 629,102 | 519,167,136 | 2023-10-17T07:09:28.581000 | Ares Commercial Real Estate Corporation, a specialty finance company, originates and invests in commercial real estate (CRE) loans and related investments in the United States. It provides a range of financing solutions for the owners, operators, and sponsors of CRE properties. The company originates senior mortgage lo... | null | 78 |
US | ACRO | NYQ | EQUITY | USD | Acropolis Infrastructure Acquisition Corp. | Financial Services | Shell Companies | 10.3 | 501 | 171,578,256 | 2023-10-17T07:09:35.377000 | Acropolis Infrastructure Acquisition Corp. does not have significant operations. The company intends to effect a merger, consolidation, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to focus a business combi... | null | 79 |
US | ACRS | NMS | EQUITY | USD | Aclaris Therapeutics, Inc. | Healthcare | Diagnostics & Research | 5.32 | 1,635,964 | 393,617,984 | 2023-10-17T07:09:42.249000 | Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments, Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therap... | null | 80 |
US | ACRV | NGM | EQUITY | USD | Acrivon Therapeutics, Inc. | Healthcare | Biotechnology | 6.06 | 30,870 | 127,139,912 | 2023-10-17T07:09:48.804000 | Acrivon Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing oncology medicines for the patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's Acrivon Predictive Precision P... | null | 81 |
US | ACRX | NGM | EQUITY | USD | AcelRx Pharmaceuticals, Inc. | Healthcare | Drug Manufacturers - Specialty & Generic | 0.6386 | 137,815 | 10,474,004 | 2023-10-17T07:09:55.027000 | AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops... | null | 82 |
US | ACST | NCM | EQUITY | USD | Acasti Pharma Inc. | Healthcare | Biotechnology | 2.57 | 5,047 | 25,190,392 | 2023-10-17T07:10:01.595000 | Acasti Pharma Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company's lead product candidate is the GTX-104, an intravenous infusion to treat subarachnoid hemorrhage. It also develops GTX-102, an oral mucosal spray for the treatment of ataxi... | null | 83 |
US | ACT | NMS | EQUITY | USD | Enact Holdings, Inc. | Financial Services | Insurance - Specialty | 27.82 | 235,427 | 4,532,630,016 | 2023-10-17T07:10:09.478000 | Enact Holdings, Inc. operates as a private mortgage insurance company in the United States. It is involved in writing and assuming residential mortgage guaranty insurance. The company offers private mortgage insurance products primarily insuring prime-based, individually underwritten residential mortgage loans; and con... | null | 84 |
US | ACTG | NMS | EQUITY | USD | Acacia Research Corporation | Industrials | Business Equipment & Supplies | 3.57 | 126,883 | 362,587,296 | 2023-10-17T07:10:17.343000 | Acacia Research Corporation, together with its subsidiaries, invests in intellectual property and related absolute return assets; and engages in the licensing and enforcement of patented technologies. The company operates through two segments, Intellectual Property Operations and Industrial Operations. The company owns... | null | 85 |
US | ACU | ASE | EQUITY | USD | Acme United Corporation | Consumer Defensive | Household & Personal Products | 26.92 | 5,115 | 102,116,448 | 2023-10-17T07:10:23.926000 | Acme United Corporation supplies first aid and safety, cutting, sharpening, and measuring products to the school, home, office, hardware, sporting goods, and industrial markets in the United States, Canada, Europe, and internationally. The company offers scissors, shears, knives, rulers, pencil sharpeners, paper trimme... | null | 86 |
US | ACV | NYQ | EQUITY | USD | Virtus Diversified Income & Convertible Fund | Financial Services | Asset Management | 18.04 | 14,590 | 187,610,128 | 2023-10-17T07:10:31.036000 | Virtus Diversified Income & Convertible Fund is a closed-ended balanced mutual fund launched and managed by Allianz Global Investors Fund Management LLC. The fund is co-managed by Allianz Global Investors U.S. LLC. It invests in the public equity and fixed income markets. The fund primarily invests in diversified portf... | null | 87 |
US | ACVA | NMS | EQUITY | USD | ACV Auctions Inc. | Consumer Cyclical | Auto & Truck Dealerships | 13.78 | 731,757 | 2,319,738,112 | 2023-10-17T07:10:37.033000 | ACV Auctions Inc. operates a digital marketplace that connects buyers and sellers for the online auction of wholesale vehicles. The company provides data services insights into the condition and value of used vehicles, as well as customer financing services. ACV Auctions Inc. was incorporated in 2014 and is headquarter... | null | 88 |
US | ACWV | BTS | ETF | USD | iShares MSCI Global Min Vol Factor ETF | null | null | 95.62 | 308,379 | 4,433,343,488 | 2023-10-17T07:10:43.505000 | The fund generally will invest at least 80% of its assets in the component securities of the underlying index and in investments that have economic characteristics that are substantially identical to the component securities of the underlying index. The index measures the combined performance of equity securities in bo... | null | 89 |
US | ACXP | NCM | EQUITY | USD | Acurx Pharmaceuticals, Inc. | Healthcare | Biotechnology | 4.34 | 632,388 | 57,872,692 | 2023-10-17T07:10:49.387000 | Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase IIa clinical trial to treat patients with clo... | null | 90 |
US | ADAG | NGM | EQUITY | USD | Adagene Inc. | Healthcare | Biotechnology | 1.46 | 7,164 | 60,491,884 | 2023-10-17T07:10:55.217000 | Adagene Inc., a clinical stage immunotherapy company, engages in the research, development, and production of monoclonal antibody drugs for cancers. The company's product candidates include ADG106, a human ligand-blocking agonistic anti- CD137 IgG4 monoclonal antibodies (mAbs) that is in Phase 1b/2 clinical trials for ... | null | 91 |
US | ADAP | NMS | EQUITY | USD | Adaptimmune Therapeutics plc | Healthcare | Biotechnology | 0.656 | 657,319 | 150,404,384 | 2023-10-17T07:11:01.005000 | Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, provides novel cell therapies primarily to cancer patients in the United States and the United Kingdom. It develops SPEARHEAD-1 that is in phase II clinical trials with ADP-A2M4 for synovial sarcoma; SURPASS-3 that is in phase II clinical trial w... | null | 92 |
US | ADBE | NMS | EQUITY | USD | Adobe Inc. | Technology | Software - Infrastructure | 548.76 | 2,166,565 | 250,751,909,888 | 2023-10-17T07:11:08.311000 | Adobe Inc., together with its subsidiaries, operates as a diversified software company worldwide. It operates through three segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products, services, and solutions that enable individuals, teams, and enterprises to c... | null | 93 |
US | ADC | NYQ | EQUITY | USD | Agree Realty Corporation | Real Estate | REIT - Retail | 54.9 | 841,522 | 5,396,997,632 | 2023-10-17T07:11:16.483000 | Agree Realty Corporation is a publicly traded real estate investment trust that is RETHINKING RETAIL through the acquisition and development of properties net leased to industry-leading, omni-channel retail tenants. As of June 30, 2023, the Company owned and operated a portfolio of 2,004 properties, located in 49 state... | null | 94 |
US | ADCT | NYQ | EQUITY | USD | ADC Therapeutics SA | Healthcare | Biotechnology | 0.8 | 96,786 | 63,707,572 | 2023-10-17T07:11:23.258000 | ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors. Its flagship product ZYNLONTA that is in Phase II clinical trial for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBC... | null | 95 |
US | ADD | NCM | EQUITY | USD | Color Star Technology Co., Ltd. | Communication Services | Entertainment | 0.5788 | 36,058 | 7,874,755 | 2023-10-17T07:11:29.975000 | Color Star Technology Co., Ltd., an entertainment and education company, provides online entertainment performances and music education services in the United States and China. The company operates Color World, an online platform of curriculum that includes music, sports, animation, painting and calligraphy, film and t... | null | 96 |
US | ADEA | NMS | EQUITY | USD | Adeia Inc. | Technology | Software - Application | 8.45 | 395,708 | 908,468,032 | 2023-10-17T07:11:37.167000 | Adeia Inc., together with its subsidiaries, operates as a media and semiconductor intellectual property licensing company worldwide. The company licenses its innovations to media and semiconductor industries and companies under the Adeia brand. It licenses its patent portfolios across various markets, including multich... | null | 97 |
US | ADER | NCM | EQUITY | USD | 26 Capital Acquisition Corp. | Financial Services | Shell Companies | 11.07 | 41,942 | 114,181,616 | 2023-10-17T07:11:44.409000 | 26 Capital Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Miami, Florida. | null | 98 |
US | ADES | NGM | EQUITY | USD | Advanced Emissions Solutions, Inc. | Industrials | Pollution & Treatment Controls | 1.96 | 45,338 | 62,222,148 | 2023-10-17T07:11:52.207000 | Advanced Emissions Solutions, Inc. provides solutions for the coal-fired power generation, industrial, water treatment plants, and other markets. The company was incorporated in 2011 and is headquartered in Greenwood Village, Colorado. | null | 99 |
US | ADEX | ASE | EQUITY | USD | Adit EdTech Acquisition Corp. | Financial Services | Shell Companies | 10.71 | 103 | 95,141,320 | 2023-10-17T07:12:00.258000 | Adit EdTech Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses or entities. Adit EdTech Acquisition Corp. was incorporated in 2020 and is based in... | null | 100 |
End of preview. Expand in Data Studio
- Downloads last month
- 29